Identifying Metabolite Biomarkers in Unstable Angina In-Patients by Feature Selection Based Data Mining Methods

Unstable angina (UA) is a most dangerous type of Coronary Heart Disease (CHD) that causing more and more mortality and morbidity world wide. Identification of biomarkers for UA in the level of metabolomics is a better avenue to understand the inner mechanism of it. We carried out clinical epidemiology to collect plasmas of UA in-patients and controls. Metabolomics data are obtained by gas chromatography techniques. We presented a novel computational strategy to select biomarkers as few as possible for UA in the data. We combined independent t test and classification based data mining methods as well as backward elimination technique to select as few as possible metabolite biomarkers with best classification performances. By the novel method, we select five metabolites for UA. The associated biomedical literatures support the finding. The novel method presented here provides a better insight into the pathology of a disease. Feature selection based data mining methods better suit to identifying biomarkers for UA

[1]  B. Wierusz-Wysocka,et al.  1,5-anhydro-D-glucitol: a novel marker of glucose excursions. , 2002, International journal of clinical practice. Supplement.

[2]  Chen Jing A comparison study of data mining algorithms in CHD clinical application , 2008 .

[3]  Wei Wang,et al.  AN UNSUPERVISED PATTERN (SYNDROME IN TRADITIONAL CHINESE MEDICINE) DISCOVERY ALGORITHM BASED ON ASSOCIATION DELINEATED BY REVISED MUTUAL INFORMATION IN CHRONIC RENAL FAILURE DATA , 2007 .

[4]  T. Uzbay,et al.  Synthesis of 4(1H)-pyridinone derivatives and investigation of analgesic and antiinflammatory activities. , 2001, Farmaco.

[5]  Yong Wang,et al.  BUILDING AND EVALUATING AN ANIMAL MODEL FOR SYNDROME IN TRADITIONAL CHINESE MEDICINE IN THE CONTEXT OF UNSTABLE ANGINA (MYOCARDIAL ISCHEMIA) BY SUPERVISED DATA MINING APPROACHES , 2009 .

[6]  O. Fiehn,et al.  Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors. , 2006, Cancer research.

[7]  E. Illenberger,et al.  Low energy electron-induced reactions in gas phase 1,2,3,5-tetra-O-acetyl-beta-D-ribofuranose: a model system for the behavior of sugar in DNA. , 2007, The Journal of chemical physics.

[8]  Dursun Delen,et al.  Predicting breast cancer survivability: a comparison of three data mining methods , 2005, Artif. Intell. Medicine.

[9]  Y. Akanuma,et al.  Reduction of plasma 1,5-anhydroglucitol (1-deoxyglucose) concentration in diabetic patients , 1988, Diabetologia.

[10]  A. Leong Diet, Nutrition, and the Prevention of Chronic Diseases , 1992 .

[11]  M. T. Clandinin,et al.  Cholesterolaemic effect of palmitic acid in relation to other dietary fatty acids. , 2002, Asia Pacific journal of clinical nutrition.

[12]  R. Écochard,et al.  Plasma fatty acids and lipid hydroperoxides increase after antibiotic therapy in cystic fibrosis , 2007, European Respiratory Journal.

[13]  W. James,et al.  A life course approach to diet, nutrition and the prevention of chronic diseases , 2004, Public Health Nutrition.

[14]  Steven A Carr,et al.  Place of pattern in proteomic biomarker discovery. , 2005, Journal of proteome research.

[15]  J. S. St. Cyr,et al.  The use of D-ribose in chronic fatigue syndrome and fibromyalgia: a pilot study. , 2006, Journal of alternative and complementary medicine.

[16]  Y. Akanuma,et al.  Plasma 1,5-Anhydro-D-Glucitol as New Clinical Marker of Glycemic Control in NIDDM Patients , 1989, Diabetes.

[17]  O. Takatani,et al.  Variations of 1-deoxyglucose(1,5-anhydroglucitol) content in plasma from patients with insulin-dependent diabetes mellitus. , 1983, Clinical chemistry.